Autism and the school nurse

Journal of School Health

Volumn 71, Issue 3, 2001, Pages 96-100

  Cade, Mary ^b   Tidwell, Sarah ^a  

^a EMPORIA STATE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADOLESCENT; AUTISM; CHILD; FEMALE; HEALTH SERVICE; HUMAN; INTERPERSONAL COMMUNICATION; MALE; NURSE PATIENT RELATIONSHIP; NURSING; ORGANIZATION AND MANAGEMENT; PATIENT EDUCATION; REVIEW; SCHOOL HEALTH NURSING; UNITED STATES;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; AUTISTIC DISORDER; CHILD; COMMUNICATION; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MALE; NURSE-PATIENT RELATIONS; PATIENT EDUCATION; SCHOOL NURSING; UNITED STATES;

EID: 0035291450     PISSN: 00224391     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1746-1561.2001.tb07300.x     Document Type: Article

References (24)

1. Mays R, Gillon J. Autism in young children. J Pediatr Health Care. 1993;7:17-23.
2. Dalton ST, Howell CC. Autism: psychobiological perspectives. J Child Adolesc Psychiatr Mental Health Nurs. 1989;2:92-96.
3. Rapin I. Autistic children: diagnosis and clinical features. Pediatrics. 1991;87(suppl):751-760.
4. Cook E. Biomedical and clinical neuroscience working group. Report presented at: treatments for people with autism and other pervasive developmental disorders: Research perspectives; November 8-9, 1999; Rockville, Md.
5. Turnbull AP, Turnbull HR, Shank M, Leal D. Autism. In: Exceptional Lives: Special Education in Today's Schools. Englecliff, NJ: Merrill-Prentice Hall; 1995:327-361.
6. Rapin I. Autism. N Engl J Med. 1997;337:97-104.
7. McDougle CJ, Brokin ES, Naylor ST, Carlson DC, Cohen DJ, Price LH. Sertraline in adults with pervasive developmental disorders: a perspective open-label investigation. J Clin Psychopharmacol. 1998;18:62-66.
8. Nagamitus S, Matsuishi T. CSF Beta-Endorphin levels in patients with infantile autism. J Autism Dev Disord. 1997;27:155-163.
9. Baerg KL. Effective communication with autistic children. Rehab Nurs. 1991;16(2):88-90.
10. Elder JH. Behavioral treatment of children with autism, mental retardation, and related disabilities: ethics and efficacy. J Child Adolesc Psychiatr Nurs. 1996:9;3:28-37.
11. Kuhn PM. Response to "Effective communication with autistic children." Rehab Nurs. 1991;16(2):19-22.
12. Coucouvanis J. Behavioral intervention for children with autism. J Child Adolesc Psychiatr Nurs. 1997:10(1):37-47.
13. Hays SR. Meeting the challenge of communicating with autistic children. Rehab Nurs. 1991;16(2):92-93.
14. Quill KA. Do-Watch-Listen-Say: Social and Communication Intervention for Children with Autism. Baltimore, Md: Paul H. Brookes; 2000.
15. Zuddas A, Ledda MG, Fratta A, Muglia P, Cianchetti C. Clinical effects of clozapine on autistic disorder. (Letter to the Editor.) Am J Psychiatry. 1996;153(5):738.
16. McDougle CJ, Holmes JP, Carlson DC, Pelton J, Cohen DJ, Price LH. Double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders. Arch Gen Psychiatr. 1998;55:633-644.
17. Nicholson R, Awad G, Sloman L. An open trial of risperidone in young autistic children. J Am Acad Child Adolesc Psychiatr. 1998;37: 372-376.
18. Sanchez LE, Campbell M, Small AM, Cueva JE, Armenteros JL, Adams PB. A pilot study of clominpramine in young autistic children. J Am Acad Child Adolesc Psychiatr. 1996;35:537-545.
19. Ricketts RW, Goza AB, Ellis CR, Singh YN, Singh NN, Cooke JC. Fluoxetine treatment of severe self-injury in young adults with mental retardation. J Am Acad Child Adolesc Psychiatr. 1993;32:865-869.
20. McDougle CJ, Naylor ST, Cohen DJ, Volkmar, FR, Heninger G, Price LH. A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatr. 1996;53:1001-1008.
21. Campbell M, Anderson L, Small AM, Adam P, Gonzalez NM, Ernst M. Naltrexone in autistic children: behavioral symptoms and attentional learning. J Am Acad Child Adolesc Psychiatr. 1993;32:1283-1291.
22. NIMH/ Autism resources page. National Institute of Mental Health Web site. Available at: http://www.nimh.nih.gov/publicat/autism.cfm. Accessed October 14, 2000.
23. Sandler AD, Sutton KA, DeWeese J, Girardi MA, Sheppard V, Bodfish J. Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder. N Engl J Med. 1999;341:1801-1806.
24. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. text revision. Washington, DC: American Psychiatric Association; 2000.